Faculty member at Department of Integrative Oncology, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
Dr. Mohammad Amin Javidi is a dedicated researcher and an Assistant Professor in the Integrative Oncology Department at the Breast Cancer Research Center, Motamed Cancer Institute, Tehran, Iran. His work primarily focuses on the molecular underpinnings of cancer and developing innovative therapeutic strategies. With a strong foundation in molecular genetics, Dr. Javidi’s research has explored the interface of cancer treatment and viral infections, particularly the impact of COVID-19 on cancer outcomes. His commitment to advancing scientific knowledge is evidenced by numerous peer-reviewed publications and a track record of academic excellence, earning him recognition in both national and international scientific communities.
Profile
ORCID
Education
Dr. Javidi’s academic journey began with a Bachelor of Science in Genetics from Shahrekord University, Iran, where he graduated top of his class in 2010. He continued to excel in his studies, pursuing a Master of Science in Molecular Genetics at Tarbiat Modares University, Tehran, Iran, graduating first in his class in 2012. His passion for genetics led him to a Ph.D. program at the same institution, where he specialized in molecular genetics, completing his degree in 2017. His doctoral research was recognized for its excellence, earning him the first rank in his graduating class, demonstrating his strong academic dedication.
Experience
With years of experience in the field of molecular genetics and oncology, Dr. Javidi has built a career around the practical application of genetic research to cancer treatment. As an assistant professor at the Motamed Cancer Institute, he conducts research that bridges molecular biology and clinical oncology, focusing on the impact of molecular changes on cancer progression and therapeutic responses. His expertise spans a variety of laboratory techniques, including PCR, cell culture, flow cytometry, and in vivo experiments, which he uses to investigate novel cancer therapies. Dr. Javidi’s experience also includes project management and leading research teams, further honing his ability to translate complex genetic data into actionable clinical insights.
Research Interest
Dr. Javidi’s primary research interests lie in understanding the molecular mechanisms that drive cancer progression and exploring therapeutic interventions. His studies have delved into the role of microRNAs in cancer, stem cell therapies, and the cytotoxic effects of natural compounds on cancer cells. The intersection of cancer treatment with viral infections, particularly the implications of COVID-19 on cancer patients, has been a significant focus of his recent work. This integrative approach not only addresses the biological aspects of cancer but also considers the broader clinical implications, aiming to improve outcomes for patients facing dual health challenges.
Awards
Throughout his career, Dr. Javidi has received several accolades in recognition of his academic and research achievements. He was awarded the first rank upon graduating from his Ph.D. program and earned the third rank in the National Ph.D. entrance exam. His innovative research has led to a national patent on producing differentiated cells using nanocarrier-loaded curcumin. He was also recognized as an elected researcher at an international symposium on imaging applications in preclinical experiments, underscoring his standing as a promising scientist in oncology.
Publications
Javidi MA, et al. Hypericin Induces Apoptosis in MDA-MB-175-VII Cells, Archives of Iranian Medicine, 2018 (Cited by 23).
Javidi MA, et al. Verapamil Inhibits Mitochondria-Induced Reactive Oxygen Species, Oxidative Medicine and Cellular Longevity, 2020 (Cited by 45).
Javidi MA, et al. Investigating Curcumin Potential for Diabetes Cell Therapy, Life Sciences, 2019 (Cited by 38).
Javidi MA, et al. Cytotoxic and Apoptogenic Effects of Hypericin on MCF-7 Human Breast Cancer Cell Line, Cancer Cell International, 2016 (Cited by 56).
Javidi MA, et al. MicroRNA-Mediated Regulation of Epithelial to Mesenchymal Transition in Cancer, Pathology and Oncology Research, 2016 (Cited by 29).
Javidi MA, et al. Dendrosomal Nanocurcumin as a Compound for In Vitro Elimination of Undifferentiated Stem Cells, Experimental and Clinical Endocrinology & Diabetes, 2015 (Cited by 47).
Conclusion
Dr. Mohammad Amin Javidi is an accomplished young scientist whose research on molecular genetics and cancer treatment places him in an excellent position for the Young Scientist Award. His commitment to advancing cancer research is evident in his academic achievements, innovative studies, and numerous publications. While his research has already made significant contributions to the field, his potential for future advancements, particularly in the context of integrative oncology and the implications of COVID-19, marks him as a valuable candidate for recognition in the scientific community.